Completed PHASE3 INTERVENTIONAL 2-arm NCT01392573

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes (DUAL™ II)

A 26-week Randomised, Parallel Two-arm, Double-blind, Multi-centre, Multinational, Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide With Insulin Degludec in Subjects With Type 2 Diabetes

Sponsor: Novo Nordisk A/S

Conditions Diabetes Diabetes Mellitus, Type 2

Interventions insulin degludec insulin degludec/liraglutide

Updated 12 times since 2017 Last updated: Dec 7, 2018 Started: Nov 28, 2011 Primary completion: Oct 1, 2012 Completion: Oct 4, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Diabetes and Diabetes Mellitus, Type 2 and is currently completed. Novo Nordisk A/S leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Feb 2019 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 7 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed PHASE3
Dec 2017 — Jun 2018 [monthly]

Completed PHASE3
Nov 2017 — Dec 2017 [monthly]

Completed PHASE3
Jul 2017 — Nov 2017 [monthly]

Completed PHASE3
May 2017 — Jul 2017 [monthly]

Completed PHASE3
Feb 2017 — May 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novo Nordisk A/S

Data source: Novo Nordisk A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Anaheim, United States , Arlington, United States , Arlington Heights, United States , Asheboro, United States , Austin, United States , Avon, United States , Basel, Switzerland , Beaver, United States , Bern, Switzerland and 69 more locations